Literature DB >> 20096534

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.

M Kusters1, C A M Marijnen, C J H van de Velde, H J T Rutten, M J Lahaye, J H Kim, R G H Beets-Tan, G L Beets.   

Abstract

AIM OF THE STUDY: In patients from the Dutch TME trial patterns of local recurrence (LR) in rectal cancer were studied. The purpose was to reconstruct the most likely mechanisms of LR and the effect of preoperative radiotherapy.
METHODS: 1417 patients were analyzed; 713 were randomized into preoperative radiotherapy and total mesorectal excision (RT + TME), 704 into TME alone. Of the 114 patients with LR, the subsites of LR were determined and related to tumor and treatment factors.
RESULTS: Overall 5-year LR-rate was 4.6% in the RT + TME group and 11.0% in the TME group. Presacral local recurrences occurred most in both groups. Radiotherapy reduced anastomotic LR significantly, except when after low anterior resection (LAR) distal margins were less than 5 mm. Abdominoperineal resection (APR) mainly resulted in presacral LR. Even after resection with a negative circumferential resection margin, LR-rates were high. Thirty percent of the patients had advanced tumors, which resulted in 58% of all LRs. Lateral LR comprised 20% of all LR. Presacral and lateral LR resulted in a poor prognosis, in contrast to anterior or anastomotic LRs with a relatively good prognosis.
CONCLUSIONS: RT reduces LR in all subsites and is especially effective in preventing anastomotic LR after LAR. APR-surgery mainly results in presacral LR, which may be prevented by a wider resection. In the TME trial many advanced tumors were included, rather requiring chemoradiotherapy instead of RT. Currently, with good imaging techniques, better selection can take place. Especially lateral LR might be a problem in the future. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20096534     DOI: 10.1016/j.ejso.2009.11.011

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  86 in total

1.  Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.

Authors:  Kah Hoong Chang; Myles J Smith; Oliver J McAnena; Arifin S Aprjanto; Joe F Dowdall
Journal:  Int J Colorectal Dis       Date:  2012-03-08       Impact factor: 2.571

2.  Therapeutic management and outcome of locoregional recurrence after curative colorectal cancer therapy-a single-center analysis.

Authors:  Pamela Kogler; Reinhold Kafka-Ritsch; Michael Sieb; Arpad Sztankay; Johann Pratschke; Matthias Zitt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

3.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Geerard L Beets; Harm J T Rutten; Miranda Kusters
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

4.  Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Authors:  Ryuichiro Sawada; Takashi Akiyoshi; Yusuke Kitagawa; Yukiharu Hiyoshi; Toshiki Mukai; Toshiya Nagasaki; Tomohiro Yamaguchi; Tsuyoshi Konishi; Noriko Yamamoto; Masashi Ueno; Yosuke Fukunaga
Journal:  Ann Surg Oncol       Date:  2021-04-19       Impact factor: 5.344

5.  Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin.

Authors:  F A Calvo; F Rivas; C V Sole; M Gómez-Espí; R Herranz; E Del Valle; M Rodríguez; E Alvarez
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

Review 6.  Patterns of local recurrence in rectal cancer after a multidisciplinary approach.

Authors:  Jose M Enríquez-Navascués; Nerea Borda; Aintzane Lizerazu; Carlos Placer; Jose L Elosegui; Juan P Ciria; Adelaida Lacasta; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 7.  Recent advances in multidisciplinary approach for rectal cancer.

Authors:  Eiji Oki; Koji Ando; Yuta Kasagi; Yoko Zaitsu; Masahiko Sugiyama; Yuichiro Nakashima; Hideto Sonoda; Kippei Ohgaki; Hiroshi Saeki; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2015-06-23       Impact factor: 3.402

8.  Endoluminal stapler prototype for rectal transection.

Authors:  F J Pérez Lara; A Ferrer Berges; H Oliva Muñoz
Journal:  Tech Coloproctol       Date:  2017-04-25       Impact factor: 3.781

9.  A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score Analysis.

Authors:  Richard Garfinkle; Maria Abou-Khalil; Sahir Bhatnagar; Nathalie Wong-Chong; Laurent Azoulay; Nancy Morin; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2018-09-27       Impact factor: 3.452

10.  Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective.

Authors:  Seo Hee Choi; Jee Suk Chang; Hong In Yoon; Dong-Su Jang; Nam Kyu Kim; Joon Seok Lim; Byung So Min; Hyuk Huh; Sang Joon Shin; Joong Bae Ahn; Woong Sub Koom
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.